rabbit anti human cd68 mab multimabtm (Cell Signaling Technology Inc)
Structured Review

Rabbit Anti Human Cd68 Mab Multimabtm, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+human+cd68+mab+multimabtm/CD68+MultiMab+Rabbit+mAb+mix/pmc12246171-307-152-156
Average 94 stars, based on 10 article reviews
Images
1) Product Images from "Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis"
Article Title: Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis
Journal: Communications Biology
doi: 10.1038/s42003-025-08425-w
Figure Legend Snippet: A.U. arbitrary unit, RT-qPCR reverse transcription quantitative polymerase chain reaction, WT THP1 WT-fortilin cells, KO THP1 KO-fortilin cells, oxLDL oxidized low density lipoprotein, αSMA alpha smooth muscle cell actin, CD68 Cluster of Differentiation 68, TCE, 2,2,2-trichloroethanol total protein staining, GAPDH glyceraldehyde-3-phosphate dehydrogenase, phMΦ primary human macrophages, CTL control, phMΦ transduced by control short hairpin RNA (shRNA control ) lentiviral particles, KD knockdown, phMΦ transduced by shRNA fortilin lentiviral particles. a Expression levels of fortilin in WT and KO cells with and without oxLDL stimulation. b – f Status of expression of VSMC markers (αSMA, SM22α, CNN1) ( b – d ) and MФ markers (Mac2, CD68) ( e , f ) in WT and KO cells as analyzed by RT-qPCR (n = 3, 3). g Western blot analysis of VSMC and MΦ markers in WT and KO cells at their baselines and upon oxLDL stimulation. h Successful KD of fortilin using shRNA fortilin lentivirus particles in phMΦ. Status of expression of VSMC markers ( i – k ) and MΦ markers ( l , m ) in CTL and KD phMΦ cells as analyzed by RT-qPCR (n = 3, 3). Data are expressed as mean ± s.d., P values determined by one-way ANOVA with Tukey multiple comparisons ( a – f , h – m ) are shown. The findings in ( g ) were confirmed in three independent experiments.
Techniques Used: Quantitative RT-PCR, Reverse Transcription, Real-time Polymerase Chain Reaction, Staining, Control, shRNA, Knockdown, Expressing, Western Blot
Related Articles
Recombinant:Article Title: Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis. Article Snippet: .. The following primary antibodies were used: • Rabbit anti-fortilin (MBL International,Woburn,MA,USA;Catalog #: PM017; 1:1,000 dilution; used for the experiments depicted in Fig. 1c); • Rabbit anti-fortilin (Abcam, Waltham, MA, USA; Clone EPR5540, ab133568; 1:2,000 dilution; Figs. 5g, S4a); • Mouse anti-GAPDH(Fitzgerald,Acton,MA,USA;Clone: 10R-G109a; 1:10,000 dilution; Fig. 1c); mouse anti-GAPDH (Santa Cruz Biotechnology, Inc. Dallas, TX, USA; Clone: 6C5; Catalog #: sc-32233; 1:1,000 dilution; Figs. 5g, S6e); • Rabbit anti-human calponin-1 (CNN1)mAb (Cell Signaling Technology (CST), Danvers, MA, USA; Clone D8L2T, Catalog #: 17819; 1:1,000 dilution; Fig. 5g); • Recombinant rabbit anti-human α-smooth muscle actin (SMA) antibody (Abcam, clone EPR5368, Catalog #: ab124964; 1:1,000 dilution; Fig. 5g); • Rabbit anti-human SM22α (Transgelin/TAGLN) polyclonal Ab (CST, Catalog #: 40471; 1:1,000 dilution; Fig. 5g); • Rabbit anti-human TGF-β1 polyclonal Ab (Abcam, Catalog #: ab92486; 1:1,000 dilution; Figs. 5g, S6e); • Rabbit anti-Mac2 (Galectin-3/LGALS3) mAb (CST, Clone: D4I2R, Catalog #: 8785; 1:1,000 dilution; Fig. 5g); Article Title: Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis Article Snippet: .. The following primary antibodies were used: Rabbit anti-fortilin (MBL International, Woburn, MA, USA; Catalog #: PM017; 1:1,000 dilution; used for the experiments depicted in Fig. ); Rabbit anti-fortilin (Abcam, Waltham, MA, USA; Clone EPR5540, ab133568; 1:2,000 dilution; Figs. , ); Mouse anti-GAPDH (Fitzgerald, Acton, MA, USA; Clone: 10R-G109a; 1:10,000 dilution; Fig. ); mouse anti-GAPDH (Santa Cruz Biotechnology, Inc. Dallas, TX, USA; Clone: 6C5; Catalog #: sc-32233; 1:1,000 dilution; Figs. , ); Rabbit anti-human calponin-1 (CNN1) mAb (Cell Signaling Technology (CST), Danvers, MA, USA; Clone D8L2T, Catalog #: 17819; 1:1,000 dilution; Fig. ); Recombinant rabbit anti-human α-smooth muscle actin (SMA) antibody (Abcam, clone EPR5368, Catalog #: ab124964; 1:1,000 dilution; Fig. ); Rabbit anti-human SM22α (Transgelin/TAGLN) polyclonal Ab (CST, Catalog #: 40471; 1:1,000 dilution; Fig. ); Rabbit anti-human TGF-β1 polyclonal Ab (Abcam, Catalog #: ab92486; 1:1,000 dilution; Figs. , ); Rabbit anti-Mac2 (Galectin-3/LGALS3) mAb (CST, Clone: D4I2R, Catalog #: 8785; 1:1,000 dilution; Fig. ); Clone Assay:Article Title: Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis. Article Snippet: .. The following primary antibodies were used: • Rabbit anti-fortilin (MBL International,Woburn,MA,USA;Catalog #: PM017; 1:1,000 dilution; used for the experiments depicted in Fig. 1c); • Rabbit anti-fortilin (Abcam, Waltham, MA, USA; Clone EPR5540, ab133568; 1:2,000 dilution; Figs. 5g, S4a); • Mouse anti-GAPDH(Fitzgerald,Acton,MA,USA;Clone: 10R-G109a; 1:10,000 dilution; Fig. 1c); mouse anti-GAPDH (Santa Cruz Biotechnology, Inc. Dallas, TX, USA; Clone: 6C5; Catalog #: sc-32233; 1:1,000 dilution; Figs. 5g, S6e); • Rabbit anti-human calponin-1 (CNN1)mAb (Cell Signaling Technology (CST), Danvers, MA, USA; Clone D8L2T, Catalog #: 17819; 1:1,000 dilution; Fig. 5g); • Recombinant rabbit anti-human α-smooth muscle actin (SMA) antibody (Abcam, clone EPR5368, Catalog #: ab124964; 1:1,000 dilution; Fig. 5g); • Rabbit anti-human SM22α (Transgelin/TAGLN) polyclonal Ab (CST, Catalog #: 40471; 1:1,000 dilution; Fig. 5g); • Rabbit anti-human TGF-β1 polyclonal Ab (Abcam, Catalog #: ab92486; 1:1,000 dilution; Figs. 5g, S6e); • Rabbit anti-Mac2 (Galectin-3/LGALS3) mAb (CST, Clone: D4I2R, Catalog #: 8785; 1:1,000 dilution; Fig. 5g); Article Title: Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis Article Snippet: .. The following primary antibodies were used: Rabbit anti-fortilin (MBL International, Woburn, MA, USA; Catalog #: PM017; 1:1,000 dilution; used for the experiments depicted in Fig. ); Rabbit anti-fortilin (Abcam, Waltham, MA, USA; Clone EPR5540, ab133568; 1:2,000 dilution; Figs. , ); Mouse anti-GAPDH (Fitzgerald, Acton, MA, USA; Clone: 10R-G109a; 1:10,000 dilution; Fig. ); mouse anti-GAPDH (Santa Cruz Biotechnology, Inc. Dallas, TX, USA; Clone: 6C5; Catalog #: sc-32233; 1:1,000 dilution; Figs. , ); Rabbit anti-human calponin-1 (CNN1) mAb (Cell Signaling Technology (CST), Danvers, MA, USA; Clone D8L2T, Catalog #: 17819; 1:1,000 dilution; Fig. ); Recombinant rabbit anti-human α-smooth muscle actin (SMA) antibody (Abcam, clone EPR5368, Catalog #: ab124964; 1:1,000 dilution; Fig. ); Rabbit anti-human SM22α (Transgelin/TAGLN) polyclonal Ab (CST, Catalog #: 40471; 1:1,000 dilution; Fig. ); Rabbit anti-human TGF-β1 polyclonal Ab (Abcam, Catalog #: ab92486; 1:1,000 dilution; Figs. , ); Rabbit anti-Mac2 (Galectin-3/LGALS3) mAb (CST, Clone: D4I2R, Catalog #: 8785; 1:1,000 dilution; Fig. ); |